Clinical Trials Browser

Terminated × INDUSTRY × ER+ HER2- Advanced Breast Cancer × Clear all

NCT03596658 2022-09-01

SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer

Phase 1 Terminated

ER+ HER2- Advanced Breast Cancer